Regulatory T cells decreased during recovery from mild covid-19 P Seepathomnarong, J Ongarj, R Sophonmanee, B Seeyankem, S Chusri, ... Viruses 14 (8), 1688, 2022 | 11 | 2022 |
T-Cell responses Induced by an intradermal BNT162b2 mRNA vaccine Booster following primary vaccination with inactivated SARS-CoV-2 vaccine R Sophonmanee, J Ongarj, B Seeyankem, P Seepathomnarong, ... Vaccines 10 (9), 1494, 2022 | 9 | 2022 |
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population N Pinpathomrat, P Intapiboon, P Seepathomnarong, J Ongarj, ... NPJ vaccines 7 (1), 52, 2022 | 9 | 2022 |
Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases P Intapiboon, P Uae-Areewongsa, J Ongarj, R Sophonmanee, ... npj Vaccines 7 (1), 149, 2022 | 3 | 2022 |
Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study P Sripongpun, N Pinpathomrat, R Sophonmanee, J Ongarj, ... Vaccines 11 (9), 1455, 2023 | 1 | 2023 |
Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study R Sophonmanee, P Preampruchcha, J Ongarj, B Seeyankem, ... Vaccines 12 (2), 109, 2024 | | 2024 |
Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases P Uea-Areewongsa, N Pinpathomrat, J Ongarj, R Sophonmanee, ... Asian Pac J Allergy Immunol, 2023 | | 2023 |
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population N Pinpathomrat, P Intapiboon, P Seepathomnarong, J Ongarj, ... npj Vaccines 7, 2022 | | 2022 |
Impaired Neutralising Antibodies to SARS-CoV-2 Omicron BA. 2 Variant and Preserved Cellular Immunogenicity Following Heterologous Prime-Boost Vaccination with an Inactivated … P Intapiboon, P Uae-areewongsa, J Ongarj, R Sophonmanee, ... Available at SSRN 4133614, 0 | | |